"Teratocarcinoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A malignant neoplasm consisting of elements of teratoma with those of embryonal carcinoma or choriocarcinoma, or both. It occurs most often in the testis. (Dorland, 27th ed)
Descriptor ID |
D018243
|
MeSH Number(s) |
C04.557.465.900
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Teratocarcinoma".
Below are MeSH descriptors whose meaning is more specific than "Teratocarcinoma".
This graph shows the total number of publications written about "Teratocarcinoma" by people in this website by year, and whether "Teratocarcinoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 1 | 0 | 1 |
1999 | 1 | 0 | 1 |
2010 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Teratocarcinoma" by people in Profiles.
-
Ferreira IL, Nascimento MV, Ribeiro M, Almeida S, Cardoso SM, Grazina M, Pratas J, Santos MJ, Janu?rio C, Oliveira CR, Rego AC. Mitochondrial-dependent apoptosis in Huntington's disease human cybrids. Exp Neurol. 2010 Apr; 222(2):243-55.
-
Delbaere A, Sidis Y, Schneyer AL. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin. Endocrinology. 1999 Jun; 140(6):2463-70.
-
Wang QF, Khoury RH, Smith PC, McConnell DS, Padmanahban V, Midgley AR, Schneyer AL, Crowley WF, Sluss PM. A two-site monoclonal antibody immunoradiometric assay for human follistatin: secretion by a human ovarian teratocarcinoma-derived cell line (PA-1). J Clin Endocrinol Metab. 1996 Apr; 81(4):1434-41.